Many ophthalmologists stress the importance to success of considering the state of the ocular surface in cataract and refractive surgery. The problem is that surgeons do not always attach the same required attention and there is not a well-defined protocol for diagnosis and treatment of ocular surface disorders. This article aims to highlight these facts and provide a guide, both simple and practical, for both diagnosis and for treatment.
the incidence of which is about 16 %, [4] [5] [6] [7] and is one of the most common reasons why people visit their ophthalmologist -approximately one in three patients seek treatment from a specialist. it is relevant and somewhat novel that in both definitions, DES and MGD, inflammation appears as a major factor in the pathogenesis. This will be important in providing a more definitive approach to diagnosis and treatment.
Cataract or refractive surgery often aggravate the symptoms of DES, 11 and there is evidence to show how these patients have poorer outcomes after surgery. 11 in patients with DES undergoing laser-assisted in situ keratomileusis (laSiK) surgery, a worsening of symptoms or onset of discomfort in patients who were previously asymptomatic, 12 or even a reduction of functional visual acuity, 13 have been described.
We also know that MGD is the most prevalent cause of evaporative dry eye. 14 Pre-existing MGD can double a patient's risk of developing DES, 15 especially after ocular surgery, which can negatively affect outcomes. [15] [16] [17] [18] [19] For these reasons it is important for ophthalmologists to consider DES and oSD whenever they approach surgical patients in order to identify and treat these conditions pre-operatively and thus optimise surgical outcomes.
Diagnosis
Traditional tests to diagnose oSD provide limited practical information. 20 Fortunately this has changed recently and the combination of clinical history, subjective symptoms and, especially, data provided by new technologies, help us with a given diagnosis. We emphasise the value of the patient's clinical history. The presence of other diseases, ocular and systemic, as well as certain medications are fundamental factors in the onset and course of the disease.
according to the DEWS report, risk factors for dry eye to be taken in account before surgery include:
• Increasing age;
• Female gender, especially women who are post-menopausal and taking oestrogen;
• Deficiencies of omega-3 and omega-6 fatty acids and vitamin A;
• Oral medications, including antihistamines, betablockers, tricyclic antidepressants and diuretics;
• Topical medications, especially those containing preservatives, such as benzalkonium chloride;
• Systemic diseases, namely autoimmune disease, including Sjögren syndrome and diabetes;
• Ocular surgery, in particular, laser vision correction and cataract surgery, especially when limbal relaxing incisions are used; and • New corneal topography: measure tear break-up time and tear meniscus height objectively (Keratograph, oculus).
• New optical coherence tomography (Fourier domain OCT) objectively quantifies the tear meniscus height and volume.
• 
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• Corneal interferometry measures the lipid layer of the tear fllm providing useful information on the functional status of Meibomian gland.
• Meibography can visualise meibomian glands (see Figure 1 ) using new topography measures with infrared light and high-resolution images (Keratograph 5M, Oculus, Arlington, WA, US).
• Confocal microscopy can show inflammation at the cellular level.
Researchers have used it to view the ductal changes that occur in MGD. Similarly, a simple-to-use, non-invasive, point-of-care test (InflammaDry Detector, RPS, Inc., Sarasota, FL, US) will be available to measure elevations in tear matrix metalloproteinase-9 levels, one of the most important inflammatory mediators that are increased in the tears of patients with OSD.
Treatment
As discussed above, DES and MGD, and also conjuntivochalasia, are frequently present in patients pre-operatively. These conditions are often overlooked, because the symptoms or signs are mild and surgeons do not consider their presence. Nonetheless, they may disturb the tear film, which could negatively affect outcomes and the patient's recovery.
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In this article, a practical guide is described to prepare patients before surgery and treatment recommendations after surgery.
Pre-operative Treatment
In patients with DES and MGD, four actions as first-line treatment are recommended: local heat, mechanical massage, cleaning of the eyelids and topical antibiotics (azithromycin). In some cases patients can benefit from adjunctive therapy with anti-inflammatory drugs, especially topical cyclosporine (Restasis, Allergan, Inc.) that has been shown to have efficacy for both blepharitis and aqueous deficiency dry eye.
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In some cases with difficult MGD, intraductal meibomian gland probing (see Figure 2) is necessary to open blocked meibomian glands to improve the quality of the secretions and thus help to stabilise the tear film. In many cases, punctal plugs are a helpful complement to prepare these patients before surgery.
Demodex folliculorum is another condition to take in account. Little is known about the extent to which this microorganism can influence the pathophysiology of DGM as a vector for bacterial colonisation. Some authors recommend using washes with tea tree oil 50 %, and provide this treatment in the office because of the potential toxicity of this substance to the cornea.
Sex hormones (androgens) are known to play an important role in regulating the function of the meibomian glands, but no studies exist that demonstrate therapeutic benefit in the DGM.
When conjunctivochalasis is present and patients are symptomatic, it is necessary to evaluate two alternatives: medical treatment with lubricants or the need for surgery (to remove the folds of conjunctiva and especially fix the conjunctiva to the sclera with bioadhesive).
Post-operative Treatment
Quick identification of the problem is crucial. In most of our patients we start post-operative treatment OSD with preservative-free artificial tears during the day and artificial tear gels or lubricants at bedtime. In symptomatic patients we recommend topical cyclosporine or low-dose dexamethasone 0.01 %. and punctual plugs.
When MGD is present we recommend topical azithromycin, either alone or in combination with oral doxycycline, if tolerated. I also instruct these patients to use warm compresses and massage their eyelids.
An artificial tear containing a lipid component can help to reduce evaporative tear loss in these patients. 
Patients with signs of partial atrophy of the meibomian glands in the upper lid (yellow arrows), initial stage [A], intermediate stage [B]) and severe stage with almost complete atrophy of the glands (C).

Figure 2: Intraductal Meibomian Gland Probing
